Ikariaincis A Critical Care Company Focused On Developing And Commercializing Innovative Therapiesdrugs And Devicesdesigned To Address The Significant Needs Of Critically Ill Patientsthe Company S Lead Product Is Inomaxa Nitric Oxidefor Inhalationthe Only Fda Approved Drug For The Treatment Of Hypoxic Respiratory Failure Associated With Pulmonary Hypertension In Term And Near Term Infantsit Is Offered Through The Inomax Therapy Packagean All Inclusive Offering Of Drug Productdrug Delivery Systemon Site Training And 24 7 365 Technical Assistance And Supportthe Inomax Therapy Package Is Marketed In The Usapuerto Ricocanadaaustraliamexico And Japan
